Am J Transplant, Volume 19, Suppl 3 Archives - Page 201 of 214 - ATC Abstracts

2019 American Transplant Congress
Enhanced Advocacy and Health Systems Training through Patient Navigation Increases Access to Living Donor Kidney Transplantation
R. D. Reed¹, V. Kumar¹, B. Berry¹, D. Hendricks¹, A. Carter¹, B. A. Shelton¹, M. N. Mustian¹, P. A. MacLennan¹, H. Qu¹, L. Hannon², C. Yates², M. J. Hanaway¹, J. E. Locke¹
¹University of Alabama at Birmingham, Birmingham, AL, ²Tuskegee University, Tuskegee, AL
*Purpose: No living donation program has addressed transplant candidate factors by separating the advocacy role from the candidates while simultaneously addressing potential living donor concerns…
2019 American Transplant Congress
Arterial Blood Pressure Circadian Rhythm in Renal Transplant Recipients
A. M. Arriaga, Y. J. Lopez, J. A. Cedillo, L. A. Marino, J. M. Mejia, I. Parra, A. Cohen, L. E. Morales
Nephrology, National Institute of Medical Sciences and Nutrition Salvador Zubirán,, Mexico City, Mexico
*Purpose: Approximately 80% kidney transplant (KT) recipients have high blood pressure, compromising graft survival and increasing cardiovascular risk. In the pre-transplant stage, alterations in blood…
2019 American Transplant Congress
Surgical Outcome and Analysis of Risk of Complications in Kidney Donors Receiving Laparoscopic Live Donor Nephrectomy
C. Yang, C. Yeh, C. Lee, C. Chen, I. Lai, P. Lee, M. Tsai
Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan
*Purpose: Laparoscopic live donor nephrectomy has adopted for more than 20 years. But the operative procedure is still technically demanding, and allows almost no margin…
2019 American Transplant Congress
Guideline Adherence for Secondary Prevention of Stroke and Atherosclerotic Cardiovascular Disease among Liver Transplant Recipients
P. T. Campbell¹, M. Kosirog¹, S. Montag², S. Connolly¹, A. Daud³, A. Das¹, S. Pine¹, D. Finn³, J. Levitsky¹, J. L. Holl⁴, D. M. Lloyd-Jones⁵, L. B. VanWagner⁶
¹Division of GI and Hepatology, Department of Medicine, Northwestern University, Chicago, IL, ²Department of Preventive Medicine, Northwestern University, Chicago, IL, ³Center for Healthcare Studies, Northwestern University, Chicago, IL, ⁴Department of Pediatrics and Center for Healthcare Studies, Northwestern University, Chicago, IL, ⁵Departments of Preventive Medicine and Medicine-Cardiology, Northwestern University, Chicago, IL, ⁶Division of GI and Hepatology, Department of Medicine and Department of Preventive Medicine, Northwestern University, Chicago, IL
*Purpose: Data about provider adherence to clinical practice guidelines for secondary prevention of stroke and atherosclerotic cardiovascular disease (ASCVD) among liver transplant recipients (LTRs), which…
2019 American Transplant Congress
Incidence and Risks for Non-alcoholic Fatty Liver Disease and Steatohepatitis Post Liver Transplant: Systematic Reveiw and Meta-Analysis
N. Saeed¹, P. Sharma², L. Glass², C. Shannon², C. Sonnenday², M. Konerman²
¹Beaumont Hospital, Ann Arbor, MI, ²University of Michigan, Ann Arbor, MI
*Purpose: Recurrent and denovo non-alcoholic fatty liver (NAFLD) and non-alcoholic steatohepatitis (NASH) are important post-liver transplant (LT) outcomes given risk to graft viability. The true…
2019 American Transplant Congress
Clinical Outcomes of Patients with Portal Vein Tumor Thrombi after Living Donor Liver Transplantation
D. Kim
Surgery, Seoul St. Mary's Hospital, Catholic University of Korea, Seoul, Korea, Republic of
*Purpose: Patient selection criteria for living donor liver transplantation(LDLT) with hepatocellular carcinoma are generally wider than those for deceased donor liver transplantation. It is widely…
2019 American Transplant Congress
Correlations between Preoperative Hepatic Venous Pressure Gradient and Graft Hemodynamics after Reperfusion in Living Donor Liver Transplantation
H. Matsushima, M. Fujiki, K. Sasaki, F. Aucejo, T. Diago Uso, C. Kwon, B. Eghtesad, C. Miller, C. Quintini, K. Hashimoto
General Surgery, Digestive Disease & Surgery Institute, Cleveland Clinic, Cleveland Clinic, Cleveland, OH
*Purpose: Hepatic venous pressure gradient (HVPG) is known to correlate with severity of portal hypertension in patients with liver cirrhosis. We retrospectively investigated the clinical…
2019 American Transplant Congress
Exendin-4 for Donor Treatment in a Brain-Death Model of Kidney Transplantation
H. Yang¹, L. Luo¹, X. Li¹, C. Long¹, Y. Shi², Y. Xiong³, M. Chen⁴, J. Gao⁵, H. Li⁶, Z. Wang⁶
¹Department of Organ Transplantation, People's Hospital of Jiangxi Province, Nanchang, China, ²Department of Pathology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, ³Department of Neurology, People's Hospital of Jiangxi Province, Nanchang, China, ⁴Department of Vascular Surgery, People's Hospital of Jiangxi Province, Nanchang, China, ⁵Department of Vascular Surgery, People's hospital of Jiangxi Province, Nanchang, China, ⁶Department of Urologic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
*Purpose: Renal grafts from brain death donors associated with poorer graft outcomes after kidney transplantation, hemodynamic and inflammatory mechanisms can account for brain death induce…
2019 American Transplant Congress
Cyclo (his-pro) Protects Against Gentamicin Induced Cell Apoptosis And Cisplatin Induced Acute Kidney Injury Through Inhibiting P53 Mediated Apoptotic Pathway.
Y. Kim¹, J. Moon¹, J. Jeong¹, J. Kim¹, S. Lee¹, M. Yu², C. Lee³, Y. Kim¹, S. Yang⁴
¹Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of, ²Internal Medicine, Hanyang University Medical Center, Seoul, Korea, Republic of, ³Internal Medicine, Cheju Halla General Hospital, Cheju, Korea, Republic of, ⁴Kidney Research Institute, Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: Cyclo(His-Pro) (CHP) is an endogenous cyclic dipeptide that exerts cellular protective effects against anti-oxdative damages. However, the role and mechanisms for CHP in preventing…
2019 American Transplant Congress
Meet Your Mate: Lessons Gleaned from Analysis of 154 Paired Kidneys Transplanted at a Single Center
M. Lubetzky¹, M. Aull², K. Rhee¹, S. Sultan², S. Kapur²
¹Division of Nephrology, New York, NY, ²Surgery, NYP-Weill Cornell, New York, NY
*Purpose: The factors affecting graft and patient survival are in many studies confounded by center and donor related factors. Mate kidney analyses can help to…